Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

Stockholders' Equity - Options Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Nov. 17, 2021	Nov. 16, 2021	Nov. 17, 2020	Nov. 16, 2020	Nov. 21, 2017	Sep. 30, 2017	Nov. 10, 2016	Nov. 09, 2016
Term number of years			5 years
Weighted average remaining contractual life of all options outstanding			5 years 6 months 10 days
Remaining contractual life for options vested and exercisable			5 years 25 days
Aggregate intrinsic value of options outstanding										$ 2,076,104
Aggregate intrinsic value of options vested and exercisable	$ 2,073,707		$ 2,073,707
Granted (in shares)			257,934
Fair value of stock options granted			$ 340,473
Fair value of vested stock options	44,243	$ 261,031	61,714	$ 301,737
Amount of unvested compensation related to stock options	$ 335,335		$ 335,335
Common stock issued upon exercise of stock options			319,550
Common Stock
Number of shares of restricted common stock issued	275,000	1,800,000	380,000	2,022,334
Common stock issued upon exercise of stock options		40,000	50,180	46,046
Employee stock options
Vesting period			3 years
Number of year(s) cliff vesting period			1 year
Term number of years			10 years
Employee stock options \| 2007 Plan
Number of shares authorized under the plan											7,000,000	5,000,000
Number of shares available for grant	0		0
Employee stock options \| 2017 Plan
Number of shares authorized under the plan									1,874,513
Number of shares available for grant	857,993		857,993
Employee stock options \| Omnibus Incentive 2017 Plan [Member]
Number of shares authorized under the plan					6,874,513	3,374,513	3,374,513	2,374,513